Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.31 | 9e-10 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-10 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-09 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |